Jarrow Formulas Women's Fem-Dophilus®
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Cruse at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
GR-1/RC-14 and Vaginal Flora (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Maltodextrin ( Non-GMO , Source ) , Cellulose and Magnesium Stearate (Vegetable Source) . Capsule Consists Of : Hydroxypropylmethylcellulose and Titanium Dioxide ( for Coloring ) .
Contains Corn and Its Derivatives. Free from Does Not Contain Declaration Obligatory Allergens.
Actual product packaging and materials may contain additional and/or different ingredient, nutritional, or proper usage information than the information displayed on our website. You are responsible ... Read More